Long-Acting Injectable Vs Sustained Release Approaches to Deliver Small Molecules, Peptides and Biologics

Session details:

Extending dosing intervals remains a key priority for improving adherence and patient experience, but selecting the right approach is far from straightforward. This panel will compare long-acting injectables, sustained release technologies, and extended release technologies, highlighting the advantages, limitations and trade-offs of each strategy. Panelists will address how to align formulation design with therapeutic goals, patient needs and lifecycle considerations.